 |
|
|
|
|
|
 Title: |
WO0064423A2:
USE OF SAREDUTANT AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO PRODUCE MEDICAMENTS USED TO TREAT OR PREVENT MOOD DISORDERS, ADJUSTMENT DISORDERS OR MIXED ANXIETY-DEPRESSION DISORDERS[French]
[ Derwent Title ]
|
Country:
Kind: |
WO World Intellectual Property Organization (WIPO)
A2 INTERNATIONAL APPLICATION PUBLISHED WITHOUT INTERNATIONAL SEARCH REPORT or INTERNATIONAL APPLICATION PUBLISHED WITH DECLARATION UNDER ARTICLE 17 (2) (A) i
(See also:
WO0064423A3 )
|
| |
| Inventor: |
EMONDS-ALT, Xavier; La Balajade, F-34980 Combaillaux, France
SOUBRIE, Philippe; Le Rey, F-34270 Valflaunes, France
STEINBERG, Régis; 699, rue du Plomidi, F-34730 Prades le Lez, France
|
| Assignee: |
SANOFI-SYNTHELABO, 174, avenue de France, F-75013 Paris, France
News, Profiles, Stocks and More about this company
|
| Published / Filed: |
2000-11-02
/ 2000-04-25
|
| Application Number: |
WO2000FR0001084
|
| IPC Code: |
Advanced:
A61K 31/435;
A61K 31/451;
A61P 25/00;
A61P 25/18;
A61P 25/22;
A61P 25/24;
C07D 211/58;
Core:
C07D 211/00;
more...
IPC-7:
A61K 31/00;
|
| ECLA Code: |
A61K31/451;
|
| Priority Number: |
|
| Abstract: |
The invention relates to the use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments that are used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders.
[French]
|
| Attorney, Agent or Firm: |
THOURET-LEMAITRE, Elisabeth ;
|
| INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report
|
| Designated Country: |
AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW,
European patent:
AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE,
OAPI patent:
BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG,
ARIPO patent:
GH GM KE LS MW SD SL SZ TZ UG ZW,
Eurasian patent:
AM AZ BY KG KZ MD RU TJ TM
|
| Family: |
Show 52 known family members
|
First Claim:
Show all claims |
REVENDICATIONS
|
Description
Expand description |
+ UTILISATION DU SAREDUTANT ET DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES POUR LA PREPARATION DE MEDICAMENTS UTILES DANS LE TRAITEMENT OU LA PREVENTION DE L'ENSEMBLE DES TROUBLES DE L'HUMEUR, DES TROUBLES DE L'ADAPTATION OU DES TROUBLES MIXTES ANXI ETE-DE PRESSION.
La présente invention a pour objet une nouvelle utilisation du sarédutant.
|
